Home | Back to newsletter main page

Case Comprehensive Cancer Center Newsletter

January 25, 2010


Elaine Borawski has been elected to serve as president of the American Academy of Health Behavior (AAHB) for 2011-2012.

FUNDING RESOURCES- Links to Funding Resources and Updated NIH Forms Available on Case CCC Website

The Case CCC Funding Resources page has links to the following important resources:

Be sure to bookmark the links for easy future reference.

FUNDING OPPORTUNITY– DOD Ovarian Cancer Research Program

The DOD is accepting applications for Ovarian Cancer Research Program (OCRP) Pilot Awards. FY10 OCRP is supporting innovative ideas that will drive the field forward and reduce the burden of ovarian cancer in the future. In addition, the OCRP is promoting unique partnerships and fostering the next generation of investigators in ovarian cancer research. These awards support conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer forward. Research priorities should include a testable hypothesis based on strong scientific rationale. Successful projects should provide a catalyst to expand or modify current thinking and/or approaches in ovarian cancer research.

Pre-Application Deadline: March 11

For more information, please click here.

FUNDING OPPORTUNITY– CanLiv's 2010 Translational Research Grants Program

CanLiv, the Hepatobiliary Cancers Foundation, is accepting applications for the 2010 Translational Research Grants Program for Cancers of the Bile Ducts and Gallbladder Young Investigators Award. This award provides funding to promising new investigators to encourage and promote translational research in cancers of the gallbladder and/or bile ducts (cholangiocarcinoma). CanLiv's definition of translational research is hypothesis-driven research that seeks to expand understanding of carcinogenic mechanisms in cancers of the liver, gallbladder and/or bile ducts and has significant likelihood to imminently lead to new therapeutic options for patients.

Applicants must hold an MD, DO, PhD or DSci degree, and be in their first to third year of a full time, primary faculty appointment in a clinical, basic, or translational science department at an academic medical institution. For foreign-trained physicians or scientists, equivalency will be determined on a case by case basis. Applicants must be tenure-track scientists at the level of Assistant Professor, but cannot be tenured or under review for tenured academic positions at the time of application submission.

Deadline March 5

For details, please click here.

FUNDING OPPORTUNITY– ACS Cancer Research Fellowship

A Call for Applications was recently released for the ACS Cancer Research Fellowship, which is intended to strengthen the field of cancer research by attracting outstanding clinicians and scientists into careers in oncology upon completion of their specialty training and to engage them in basic or clinical academic cancer research. The fellowship is not intended for those already on a research track.

Deadline: March 3

For more information, please click here.


The Small Molecule Screening Core (SMSC) has negotiated an opportunity to order shRNA clones from Sigma (in the form of glycerol stocks) for LRI and CWRU researchers for a very low price on a per clone basis. To order, please contact Anna Kondratova (kondraa@ccf.org, 445-3503). The next order will be in March, but existing clones can be purchased at any time.

Also, the SMSC has small aliquots of secondary antibodies available for purchase; each set is conjugated with DyLight 488 and DyLight 594 fluorescent dyes (Jackson ImmunoResearch Laboratories). The antibodies work well in place of fluorescein/Alexa488 & Texas Red conjugates.

Please click here for more information.

CALL FOR APPLICATIONS– 2010 NASA Space Radiation Summer School

Applications are now being accepted for the 2010 NASA Space Radiation Summer School. Up to 15 students will be selected for the course to be held this summer at the Brookhaven National Laboratory (BNL) in Long Island, NY from May 20 – June 11. The goal of the course is to provide scientific and practical information to students and scientists who are either new to the NASA program or to charged particle radiobiology. At the completion of the summer school, students will have received the full complement of training required to conduct their own experiments at BNL.

Both foreign nationals and US citizens may apply to the program. All selected students must satisfy BNL and Department of Energy safety and security requirements in order to be admitted. Due to the intense nature of the course, applicants must demonstrate oral and written proficiency in the English language.

Deadline: February 28

For more information, please click here.

FUNDING OPPORTUNITY— Title Recovery Act Limited Competition: NIH Director's Opportunity for Research in Five Thematic Areas (RC4)

NIH is accepting applications for the "Title Recovery Act Limited Competition: NIH Director's Opportunity for Research in Five Thematic Areas" (RC4) (RFA-OD-10-005).

This program will support projects that address research endeavors in specific areas that will benefit from significant three-year funds without the expectation of continued NIH funding beyond this period. The research supported by the program should have high short-term impact, and a high likelihood of enabling growth and investment in biomedical research and development, public health, and health care delivery.

This FOA solicits applications proposing to develop and implement critical research innovations in one or more of the following five thematic areas:

  1. Applying Genomics and Other High Throughput Technologies
  2. Translating Basic Science Discoveries into New and Better Treatments
  3. Using Science to Enable Health Care Reform
  4. Focusing on Global Health
  5. Reinvigorating the Biomedical Research Community

Only applications for projects that require $500,000 or more in total costs per year are expected to be considered for funding.

LOI Deadline: February 15 (requested, not required)
Proposal Deadline: March 15

For details, please click here.

Case CCC Leadership would like to review potential responses, and can assist in developing themes as responsive to the RFA.


**All events are open to anyone interested in attending

January 25

Pathology Research Seminar
Scott Kern, MD
Associate Professor, Oncology
Johns Hopkins University
Topic: Lessons from Pancreatic Cancer Genetics
12:00 pm WRB 1413

Physiology & Biophysics Seminar
Sean Decatur, PhD
Dean of Arts and Sciences
Professor, Chemistry
Oberlin College
Topic: Protein Structure, Dynamics, and Aggregation Probed by Isotope-Edited Infrared Spectroscopy
4:00 pm SOM E501

January 26

Immunology Seminar
Feng Lin, PhD
Assistant Professor, Pathology
Topic: Complement in Autoimmunity and Bone Biology
12:00 pm WRB 1413

Taussig Cancer Institute Core Curriculum Series
Dale Shepard, MD
Fellow, Hem/Onc
Cleveland Clinic
Topic: Overview of Cancer Pharmacology- Part I
12:00 pm R3-002 Cleveland Clinic

January 27

Grand Rounds
Cheng-Kui Qu, MD, PhD
Associate Professor, Medicine- Hem/Onc
Topic: Tyrosine Phosphatase PTPN 11 (SHP2) in Childhood Leukemia: What We Have Learned from the Mouse Model
8:00 am Lerner B-151

Pathology Student Seminar
Dan Xu
Qu Lab, Pathology
Topic: Effects of Activating Mutations in SHP-2 (PTPN11) Phosphatase on Hematopoietic Cell Development
12:00 pm WRB 1413

January 28

Inflammation, Infection and Cancer Focus Group Meeting cancelled

Taussig Cancer Institute Core Curriculum Series
Dale Shepard, MD
Fellow, Hem/Onc
Cleveland Clinic
Topic: Overview of Cancer Pharmacology- Part II
12:00 pm R3-002 Cleveland Clinic

Neurosciences Seminar
Douglas McMahon, PhD
Professor, Biological Sciences and Pharmacology
Vanderbilt University
Topic: A Hard Days Night: Light, Serotonin and the Brain's Biological Clock
12:10 pm BRB 105

Case CCC Scientific Series: TREC
4:00-7:00 pm WRB 1413

January 29

Hem/Onc Fellows Seminar
Tycel Phillips, MD
Fellow, Div. of Hem/Onc
Topic: Non-Myeloablative Stem Cell Transplant for Sickle Cell Anemia
8:00 am Wearn 137

Taussig Cancer Institute Grand Rounds
Athanassios Argiris, MD
Associate Professor, Medicine- Hem/Onc
University of Pittsburgh
Topic: Lung Cancer Therapeutics in 2010
8:00 am R3/002-003 Cleveland Clinic

Cancer Center Seminar Series/ Blood Club
Jeremy Rich, MD
Chairman and Professor, Stem Cell Biology & Regenerative Medicine
CWRU/ Cleveland Clinic
Topic: Potential Implications of Cancer Cells in Brain Tumor Biology
12:00 pm BRB 105

Cancer Center Research in Progress Seminar
Snehal Dabir, PhD
Post-doc, Dowlati Lab, Div. of Hem/Onc
Topic: PIAS3, A Negative Regulator of STAT3 Signaling, Has Multiple Transcriptional Effects
4:00 pm WRB 3-136


For a complete listing of LRI seminars click here.


Olof Pearson Lecture
February 5
12:00 pm WRB 1-413
Speaker: V. Craig Jordan, PhD
Scientific Director, Lombardi Cancer Center
Vincent T. Lombardi Chair of Translational Cancer Research
Georgetown University
Topic: Estrogen in the Life and Death of Breast Cancer

Case CCC Scientific Retreat
July 9-10
The Lodge at Sawmill Creek Resort


12th International Symposium on Anti-Angiogenic Agents: Angio 2010 Recent Advances and Future Directions in Basic and Clinical Cancer Research
February 4-6
Hyatt Regency La Jolla, San Diego, CA

AACR-JCA 8th Joint Conference on Cancer Genomics, Epigenomics, and the Development of Novel Therapeutics
February 5-9
Hilton Waikoloa Village, Waikoloa, HI

13th Annual Meeting of the Translational Research Cancer Centers Consortium
March 1-2
Blackwell Inn, Columbus, OH

AACR 101st Annual Meeting
April 17-21
Washington, DC

MARK YOUR CALENDARS– NCI 3rd Annual Biospecimen Research Network Symposium

Registration is now open and abstracts are being accepted for NCI's 3rd Annual Biospecimen Research Network Symposium, Advancing Cancer Research Through Biospecimen Science, March 24-25 in Bethesda, Maryland. The symposium will address the significant impact of pre-analytical biospecimen variables on cancer research and molecular medicine. Hosted by NCI's Office of Biorepositories and Biospecimen Research, the meeting will bring together leaders in the fields of biospecimen research, genomics, proteomics, oncology, pathology, biobanking, hospital administration and pharmaceutics as well as patient advocates.

For details, please click here.

CALL FOR APPLICATIONS– K12 Clinical Oncology Research Training Program

The Case CCC invites applications for its two-year NCI-funded K12 Clinical Oncology Research Training Program, led by Stanton Gerson, MD, Director, and Alvin Schmaier, MD, Co-Director.

This career development program provides interdisciplinary training in clinical and translational oncology research for clinical oncologist who are interested in pursuing academic research careers as oncology physician scientists.

Application Deadline: February 28
Start Date: July 1

For more information and application materials, please click here.

FACULTY CANDIDATE SEARCH– Associate Director for Basic Research

The Case CCC is currently accepting applications for the position of Associate Director for Basic Research. As we continue our search, we ask that people in the Cancer Center community encourage any qualified candidate to apply for the position. If you would like to nominate someone for the position, please contact Tracy Rehl (tracy.rehl@case.edu).

Click here to view the job description.


We are always trying to foster communication and collaboration across the cancer center community any way that we can. The Case CCC has set up a page on Facebook and LinkedIn, so please become a fan of us on Facebook or join our group on LinkedIn, and encourage others to do so as well. Please help us spread the word.

We encourage you to post events, relevant news articles, items of discussion, etc… Your feedback is appreciated!


Prostate Cancer Foundation Creativity Awards
Deadline: January 31

IOTF Clinical Oncology Product Research/Review for Oncology Fellows
Deadline: January 31

IOTF Clinical Oncology Product Research/Review for Board Certified (BC) Oncologists
Deadline: January 31

ACS Ohio Division Joseph S. Silber Student Summer Fellowship
Deadline: February 3

Multiple Myeloma Research Foundation 2009 Seniors Award Program
Deadline: February 3

Leukemia Research Foundation Hollis Brownstein Research Grants Program
Deadline: February 15

Ohio Cancer Research Associates
Deadline: February 19

AICR Investigator Initiated Grants
Deadline: February 19

AICR Matching Grants
Deadline: February 19

AICR Postdoctoral Awards
Deadline: February 19

Hope Street Kids
Deadline: March 1

IOTF Oncology Product Research/Review Fellows
Deadline: May 30

IOTF Cancer Prevention Fellows
Deadline: September 1

AACR Scholar-in-Training Awards - Special Conferences
Deadline varies

NCI Short-Term Scientist Exchange Program
Deadline: Open

James S. McDonnell Foundation
Deadline: Open

NIH Bulletin – Notices and Funding Opportunities

FY2010 Recovery Act Funding Announcements: Clarification on Page Limitations for Bibliography and References Cited Section (NOT-OD-10-051)

Clarification of SF424 (R&R) Application Instructions for Resubmissions of Revision and Renewal Applications (NOT-OD-10-052)

Notice of Availability of Administrative Supplements for Activities to Promote Research Collaborations for Projects Currently Funded by the NCI Division of Cancer Biology (NOT-CA-10-015) National Cancer Institute

Produced by:
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
216-844-8317 phone
216-844-7832 fax


If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!

Send items to gillian.irwin@case.edu.

If you have trouble viewing this page, click here to view the newsletter online on our website.